



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Sunday,
                        10 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

377






                                    ANSWERED ON: 
                                

19.11.2019






Generic Medicines




Ajay Nishad














                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















Will the Minister of CHEMICALS AND FERTILIZERS, be pleased to state: (a) whether the Government proposes or has made it mandatory for the doctors to prescribe only the low priced generic medicines for the patients; (b) if so, the steps taken/proposed to be taken by the Government for monitoring the medicines prescribed by the doctors or sold by the pharmacies; (c) whether the Government has taken any steps to encourage the use of indigenous manufactured medicines; and (d) if so, the details thereof?






ANSWER




MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS(SHRI D. V. SADANANDA GOWDA)(a) & (b): Ministry of Health & Family Welfare vide their Circular dated 08.04.2015 has directed all the specialists/ Doctors working in Central Government Health Scheme (CGHS) to ensure that generic drugs are prescribed to the maximum extent possible with a view to make medical treatment cost effective and affordable. Further, Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs. Director, CGHS has vide Office Memorandum dated 08.09.2017, issued instructions to all CGHS Wellness Centres to ensure that prescription is only by generic name wherever generic drugs are available. Medical Council of India (MCI) has issued Circulars dated 21.04.2017, 22.11.2012 and 18.01.2013 vide which all the Registered Medical Practitioners have been directed to comply with the aforesaid provisions. The MCI or the appropriate State Medical Councils have been empowered to take disciplinary action against a doctor for violation of the provisions of the aforesaid Regulations. As and when complaints are received against the violation of these, such complaints are referred by MCI to the concerned State Medical Councils where the doctors/medical practitioners are registered for appropriate action.(c) & (d):	Following steps have been taken by the Government to promote the use of domestically manufactured drugs and medicines:(i)	National Pharmaceuticals Pricing Policy, 2012 (NPPP-2012) was notified with the objective to put in place a regulatory framework for pricing of drugs so as to ensure availability of required medicines – “essential medicines” at reasonable prices even while providing sufficient opportunity for innovation and competition to support the growth of pharma industry thereby meeting the goals of employment and shared economic well-being for all.(ii)	In order to promote and to make available quality generic medicines at affordable prices to all through specific outlets, a scheme in the name of ‘PradhanMantriBhartiyaJanaushadhiPariyojana’ (PMBJP) is functioning across the country. As on 15.11.2019, 5,760 PMBJP Kendras are functional in 33 States/Union Territories of the country. (iii)	In order to promote domestically manufactured drugs, the Government is providing financial support for research and development through Drugs & Pharmaceuticals Research Programme (DPRP) run by the Department of Science & Technology. The companies undertaking Research & Development activities are provided income tax benefits. (iv)	The Drugs (Prices Control) Order, 2013, Para-32(iii) provides exemptions from price control to a manufacturer producing a new drug involving a new delivery system developed through indigenous Research and Development for a period of five years from the date of its market approval in India. (v)	The government vide its notification dated 28th January, 2016 has withdrawn exemption of customs duty on certain categories of Bulk Drugs/APIs to provide level playing field to the domestic manufacturers. (vi)	The government is facilitating all kinds of clearances required by the manufacturers to give a boost to domestic manufacturing of bulk drugs.(vii)	In order to encourage ‘Make in India’ and to promote manufacturing and production of goods and services in India, the Department of Pharmaceuticals vide its Order No. 31026/4/2018-Policy dated 01.01.2019 has notified Public Procurement (Preference to Make in India), Order, 2017, for Pharmaceutical Formulations. xxxxx
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113115669







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







